Stocks · Korea
420570
KOSDAQ
J2kbio
An overview for this page is not available in English yet. The figures below are updated daily.
Key figures 2026-10-07 basis
PER21.68x
PBR1.72x
EPS459 KRW
BPS5,775 KRW
ROE11.88%
Dividend yield2.51%
DPS250 KRW
Payout ratio54.47%
Returns and 52-week range
1W+3.86%
1M+5.51%
3M+19.88%
6M+25.95%
1Y+2.05%
YTD+10.07%
52W high12,860원
52W low6,710원
From 52W high-22.63%
Financial results (consolidated)
| Period | Revenue | Operating income | Net income | OP margin |
|---|---|---|---|---|
| 2023 | 285억 | 56억 | 48억 | 19.7% |
| 2024 | 331억 | 36억 | -17억 | 10.9% |
| 2025 | 330억 | 29억 | 27억 | 8.9% |
| Quarterly | ||||
| 2024 4Q | 68억 | 11,477,182원 | 3억 | 0.2% |
| 2025 1Q | 73억 | 3억 | 2억 | 4.6% |
| 2025 2Q | 85억 | 7억 | 9억 | 8.2% |
| 2025 3Q | 86억 | 12억 | 8억 | 14.6% |
| 2025 4Q | 86억 | 6억 | 7억 | 7.4% |
| 2026 1Q | 111억 | 19억 | 16억 | 17.2% |
Company
Address: 충청북도 청주시 청원구 오창읍 두릉유리로 50-3
Peers in the same sector
Recent filings
- 2026-08-12반기보고서 (2026.06)
- 2026-05-14분기보고서 (2026.03)
Source: DART (Financial Supervisory Service electronic disclosure)
Recent news
- 2026-05-14제이투케이바이오, 1분기 영업이익 19억…전년比 476.6%↑ 뉴시스
- 2026-05-14제이투케이바이오, 1Q 영업익 476% 급증…"K뷰티 수혜 본격화" 이데일리
- 2026-05-14제이투케이바이오, 1Q 영업이익 19억원…전년比 476%↑ 아시아경제
Sources and notes
This page summarizes public filings, market data and news for information only. It is not a recommendation to buy or sell any security. Figures are as of the dates shown; check the original filings before making decisions.